Glenmark Pharmaceuticals Ltd - Stock Price

As on7 May 2021
  • NSE : GLENMARK
  • BSE : 532296
  • ISIN CODE : INE935A01035
  • Industry : Pharmaceuticals & Drugs
  • House : Glenmark
Glenmark Pharmaceuticals Ltd is not traded on BSE/NSE
591.50
+3.74 %+21.35
Previous Close 570.15
Day's Open 571.00
Bid Price (Qty) 591.50 (2045)
Offer Price (Qty) 0.00 (0)
Day’s High - Low 602.70 - 565.10
52 Week Range 325.55 - 602.7
Volume Traded (in 000's) 12763.13
Value traded (in Cr.) 756.97
PE Ratio (x) 10.08
M Cap (in Cr.)16698.71

Glenmark Pharmaceuticals Ltd Stock Price

03/02/2017 | 15:19
  • Current Price8741.20
  • Open8735.15
  • High8748.25
  • Low8707.75
  • Prev. Close8734.25

Fundamentals

Parameter Values
Market Cap (Rs. in Cr.) 16698.71
Earning Per Share (EPS TTM) (Rs.) 58.72
Price To Earnings (P/E) Ratio 10.08
Book Value Per Share (Rs.) 497.03
Price/Book (MRQ) 1.19
Price/Earning (TTM) 9.25
ROCE (%) 11.24
PAT Margin 20.18
Dividend Yield 0.42
Face Value 1

Financial Summary

Parameter MAR 20 (`Mn.) MAR 19 (`Mn.) YoY %Change
Balance Sheet :
Share Capital282.17282.170.00
Total Non-Current Liabilities30330.0622799.3933.03
Total Current Liabilities41259.8340210.942.61
Total Liabilities132291.02119058.4011.11
Total Non-Current Assets64254.8652090.1523.35
Currents Investments0.000.000.00
Cash and Bank11112.429377.6518.50
Total Current Assets68036.1666968.251.59
Total Assets132291.02119058.4011.11
Profit & Loss :
Gross Sales106410.0098655.007.86
Net Sales106410.0098655.007.86
Total Expenditure89429.0082797.008.01
Operating Profit18577.0017939.003.56
Profit After Tax7760.009250.00-16.11
More from Financial Summary »

held by Mutual Fund Schemes

Scheme Holding(%)  
More from Held By MF Schemes »

News & Updates

  • There is no news in this stock

Share Holdings

Description Percent of Share (%)
Promoters46.63
Non-Institution18.38
Mutual Funds/Uti3.27
Fi/Banks/Insurance0.55
Government0
FII0
More from Share holdings »

Corporate Information

Management Info

  • Chairman: Glenn Saldanha
  • Managing Director: Glenn Saldanha
  • Secretary: Harish Kuber

Registered Office

Address : B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai,
Maharashtra-400026
Tel : Fax : Email : webmaster@glenmarkpharma.com Website : www.glenmarkpharma.com

Registars Details

K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. was incorporated in the year 1977. Its today's share price is 591.8. Its current market capitalisation stands at Rs 16698.71 Cr. In the latest quarter, company has reported Gross Sales of Rs. 67126.31 Cr and Total Income of Rs.73194.19 Cr. The company's management includes Dipankar Bhattacharjee, Harish Kuber, Saira Ramasastry, D R Mehta, B E Saldanha, Sridhar Gorthi, Bernard Munos, Brian W Tempest, Rajesh V Desai, VS Mani, Cherylann Pinto, Glenn Saldanha, Glenn Saldanha.

It is listed on the BSE with a BSE Code of 532296 , NSE with an NSE Symbol of GLENMARK and ISIN of INE935A01035. It's Registered office is at B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai-400026, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Arthur Andersen & Associates, Price Waterhouse, VK Bahri & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

Latest News

close